Is there a list of new features requested or bugs that need to be fixed. How would developers contribute if the were just getting involved on some volenteer part time basis?
-
-
Hello Ashreid,
We would love to have more people contributing to the codebase.
Getting started, I would first make sure you can:- Clone the source from github and build openge (See the developer docs for compilation instructions)
- Run the tests (make test)
- Branch the source so you have something to develop against
We don't have a public list of features and bugs to work on, but here are a couple of things off the top of my head:- Add additional testing. Most of the built in tests simply execute openge with valid inputs, but don't check the output of tests. More robust testing would be useful to us. Check out run.sh from this test that I just checked in for an example: here
I have been meaning to verify that we have full test coverage for both SAM and BAM inputs, being passed in as a filename, as well as piped into OpenGE. A good test (or set of tests) would verify that we can run:
just as well asCode:cat asdf.bam | ./openge count
orCode:./openge asdf.bam
Complete test coverage of all input types would be helpful; IO code is where we find the most bugs currently.Code:./openge count < asdf.bam.
- The CMake build system supports building packages for linux platforms (see here). It would be great if we could build .deb and .rpm packages with a command that included the appropriate binary and referenced necessary dependencies.
- Additional features. If you're interested on working on additional features, we will need to coordinate with David (adaptivegenome). He's the guy in charge of deciding what goes into openge.
If you have patches to contribute, please branch the openge source on github and submit a pull request with your modifications and we'll have a look.
-Lee
-
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...07-31-2026, 11:01 AM -
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...07-20-2026, 11:48 AM -
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...07-09-2026, 11:10 AM
Comment